NCT00418834
Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)
See it on ClinicalTrials.gov ↗1,053 people
53.5%
46.5%
563 womenmiddle line = equal numbers490 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2008-10
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 65 Years – no maximum
- Average age
- mean 71.2 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 721 Participants
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 95.7% · Black / African American 3.6% · Asian 0.5% · Native Hawaiian / Pacific Islander 0.1% · More than one race 0.1%
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.